ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,209,180, issued on Jan. 28, was assigned to REGENERON PHARMACEUTICALS INC. (Tarrytown, N.Y.).
"Bis-octahydrophenanthrene carboxamide derivatives and protein conjugates thereof for use as LXR agonists" was invented by Jesper A. Gromada (Concord, Mass.), Viktoria Gusarova (Pleasantville, N.Y.), Amy Han (Hockessin, Del.), Sokol Haxhinasto (Brookfield, Conn.), Andrew J. Murphy (Croton-on-Hudson, N.Y.), William Olson (Yorktown Heights, N.Y.) and Matthew Sleeman (Yorktown Heights, N.Y.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds or payloads, linker-payloads, antibody-drug conjugates, and compositions, and methods for the treat...